Kan Yang

415 total citations
34 papers, 308 citations indexed

About

Kan Yang is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Kan Yang has authored 34 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Organic Chemistry and 9 papers in Pharmacology. Recurrent topics in Kan Yang's work include Synthesis and biological activity (7 papers), Sphingolipid Metabolism and Signaling (7 papers) and Cancer therapeutics and mechanisms (4 papers). Kan Yang is often cited by papers focused on Synthesis and biological activity (7 papers), Sphingolipid Metabolism and Signaling (7 papers) and Cancer therapeutics and mechanisms (4 papers). Kan Yang collaborates with scholars based in China, United States and United Kingdom. Kan Yang's co-authors include Yali Song, Martin Lipkin, Jinxin Wang, Xiaoqiang Qiao, Zhenming Liu, Fei Cao, Youzhi Wang, Jiajia Feng, Siran Feng and Xinyue Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Journal of Lipid Research.

In The Last Decade

Kan Yang

31 papers receiving 305 citations

Peers

Kan Yang

PHARM

CTM

SURGE

Mayumi Shikano Japan

Yanshen Guo China

Asha Kulkarni‐Almeida India

X. D. Sheng China

Maria Alessandra Alisi Italy

Jayanta Dowarah India

Chandrani Fouzder India

Balázs Balogh Hungary

Mayumi Shikano Japan

Kan Yang

136 ×1.0

105 ×1.0

93 ×1.3

PHARM

16 ×0.4

CTM

31 ×1.1

SURGE

Citations per year, relative to Kan Yang Kan Yang (= 1×) peers Mayumi Shikano

Countries citing papers authored by Kan Yang

Since Specialization

Citations

This map shows the geographic impact of Kan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kan Yang more than expected).

Fields of papers citing papers by Kan Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kan Yang. The network helps show where Kan Yang may publish in the future.

Co-authorship network of co-authors of Kan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Kan Yang. A scholar is included among the top collaborators of Kan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kan Yang. Kan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Han, MeiLan K., Sen Pang, Hua‐Jie Zhu, et al.. (2025). Modulating culture method promotes the production of disulfide-linked resorcylic acid lactone dimers with anti-proliferative activity. Bioorganic Chemistry. 159. 108418–108418. 2 indexed citations

Li, Yanan, Yiming Wang, Longfei Li, et al.. (2024). Discovery and biological evaluation of biaryl acetamide derivatives as selective and in vivo active sphingosine kinase-2 inhibitors. European Journal of Medicinal Chemistry. 275. 116577–116577. 1 indexed citations

Gu, Chenglei, Chen Zhou, Chunqin Mao, et al.. (2024). Insights into direct KRAS inhibition strategies for cancer treatment. Future Medicinal Chemistry. 16(22). 2411–2429. 1 indexed citations

Liu, Han, Jinze Li, Yibo Zhang, et al.. (2024). Regulation of post-translational modification of PD-L1 and associated opportunities for novel small-molecule therapeutics. Future Medicinal Chemistry. 16(15). 1583–1599.

Hu, Xiao, Xuan Wang, Ting Li, et al.. (2024). Discovery of a Novel ASM Direct Inhibitor with a 1,5-Diphenyl-pyrazole Scaffold and Its Antidepressant Mechanism of Action. Journal of Medicinal Chemistry. 67(12). 10350–10373. 3 indexed citations

Hao, Yuchen, et al.. (2024). Modulators for palmitoylation of proteins and small molecules. European Journal of Medicinal Chemistry. 271. 116408–116408. 11 indexed citations

Wang, Youzhi, et al.. (2023). Design and synthesis of a novel class of PDE4 inhibitors with antioxidant properties as bifunctional agents for the potential treatment of COPD. European Journal of Medicinal Chemistry. 256. 115374–115374. 8 indexed citations

Yang, Kan, Xinyue Zhu, Tian Gao, et al.. (2023). Design, synthesis and biological evaluation of dual Topo II/HDAC inhibitors bearing pyrimido[5,4-b]indole and pyrazolo[3,4-d]pyrimidine motifs. European Journal of Medicinal Chemistry. 252. 115303–115303. 18 indexed citations

Chen, Jichao, Kan Yang, Jiahe Wang, et al.. (2023). Design, synthesis and biological evaluation of novel 9-N-substituted-13-alkylberberine derivatives from Chinese medicine as anti-hepatocellular carcinoma agents. Bioorganic & Medicinal Chemistry. 79. 117156–117156. 5 indexed citations

10.

Yu, Wei, Kan Yang, Han Liu, et al.. (2023). Design, synthesis and biological activity evaluation of novel covalent S-acylation inhibitors. Molecular Diversity. 28(3). 1073–1092. 4 indexed citations

11.

Wang, Shasha, Jinmiao Zhang, Longfei Li, et al.. (2023). Design, synthesis, antitumor activity, and molecular dynamics simulations of novel sphingosine kinase 2 inhibitors. Bioorganic & Medicinal Chemistry. 93. 117441–117441. 3 indexed citations

12.

Wang, Youzhi, Yulong Wang, Hui‐Fang Wang, et al.. (2022). Sappanone A: A natural PDE4 inhibitor with dual anti-inflammatory and antioxidant activities from the heartwood of Caesalpinia sappan L.. Journal of Ethnopharmacology. 304. 116020–116020. 24 indexed citations

13.

Wang, Ke, Huifang Wang, Botao Zhang, et al.. (2022). Discovery of selective covalent cathepsin K inhibitors containing novel 4-cyanopyrimidine warhead based on quantum chemical calculations and binding mode analysis. Bioorganic & Medicinal Chemistry. 74. 117053–117053.

14.

Shang, Yanguo, Minghui Wang, Tao Meng, et al.. (2022). Development of indole-2-carbonyl piperazine urea derivatives as selective FAAH inhibitors for efficient treatment of depression and pain. Bioorganic Chemistry. 128. 106031–106031. 8 indexed citations

15.

Han, Chuang, et al.. (2020). Design, synthesis and evaluation of new 4-arylthiazole-2-amine derivatives as acetylcholinesterase inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(6). 126985–126985. 24 indexed citations

16.

Song, Yali, Siran Feng, Jiajia Feng, et al.. (2020). Synthesis and biological evaluation of novel pyrazoline derivatives containing indole skeleton as anti-cancer agents targeting topoisomerase II. European Journal of Medicinal Chemistry. 200. 112459–112459. 35 indexed citations

17.

Yang, Kan, et al.. (2020). Discovery of Potent, Selective, and Direct Acid Sphingomyelinase Inhibitors with Antidepressant Activity. Journal of Medicinal Chemistry. 63(3). 961–974. 19 indexed citations

18.

Zhang, Xiaozhong, et al.. (2019). Synthesis, in vitro assays, molecular docking, theoretical ADMET prediction, and evaluation of 4-methoxy-phenylthiazole-2-amine derivatives as acetylcholinesterase inhibitors. Medicinal Chemistry Research. 28(10). 1683–1693. 13 indexed citations

19.

Yang, Kan, et al.. (2013). [Anti-apoptosis and expression of microRNA-21 in rat myocardium during early ischemia-reperfusion injury].. PubMed. 38(5). 483–9. 4 indexed citations

20.

Sehayek, Ephraim, Jennie G. Ono, Elizabeth M. Duncan, et al.. (2001). Hyodeoxycholic acid efficiently suppresses atherosclerosis formation and plasma cholesterol levels in mice. Journal of Lipid Research. 42(8). 1250–1256. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact